secwatch.observer — SEC 8-K summary
======================================

Issuer:     EKSO BIONICS HOLDINGS, INC. (CHRN)
CIK:        0001549084
Form:       8-K
Filed at:   2026-06-30T20:43:26+00:00
Accession:  0001493152-26-031298
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ChronoScale appoints Andrew Schaap to board, grants 200,000 restricted shares
-----------------------------------------------------------------------------

- Board expanded from 7 to 8 members; Schaap appointed effective June 29, 2026.
- Schaap joins Audit Committee (replacing Douglas Miller) and Related Party Transactions Committee.
- Schaap receives 200,000 restricted shares vesting 50% on each of first two anniversaries.
- Subsidiary has a data center lease with a company where Schaap is CEO; lease was in ordinary course.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1549084/000149315226031298/0001493152-26-031298-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1549084/000149315226031298/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-031298

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer